Bayer’s KERENDIA wins FDA approval as first new CKD treatment in 30 years
AI Summary- Bayer received FDA approval for KERENDIA (finerenone)
- KERENDIA is the first new treatment in 30 years for this group
- The approval covers adults with CKD and Type 1 diabetes